BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1966958)

  • 1. Binding of radiolabeled MAb B72.3 administered intravenously and intraperitoneally in colorectal cancer patients. An overview.
    Schlom J; Siler K; Colcher D; Carrasquillo JA; Reynolds JC; Sugarbaker P; Larson SM
    Acta Radiol Suppl; 1990; 374():123-8. PubMed ID: 1966958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.
    Colcher D; Esteban J; Carrasquillo JA; Sugarbaker P; Reynolds JC; Bryant G; Larson SM; Schlom J
    Cancer Res; 1987 Aug; 47(15):4218-24. PubMed ID: 3607761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vivo application of monoclonal antibodies in the management of human carcinomas].
    Ohuchi N; Colcher D; Schlom J
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1109-14. PubMed ID: 3291770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of biotinylated monoclonal antibodies (B72.3 and F023C5) in patients with colorectal cancer.
    Mangili F; Stella M; Sassi I; Ferrara F; Paganelli G; De Nardi P; Cantaboni A
    Eur J Histochem; 1993; 37(1):53-7. PubMed ID: 7682868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimates of radiation absorbed dose for intraperitoneally administered iodine-131 radiolabeled B72.3 monoclonal antibody in patients with peritoneal carcinomatoses.
    Larson SM; Carrasquillo JA; Colcher DC; Yokoyama K; Reynolds JC; Bacharach SA; Raubitchek A; Pace L; Finn RD; Rotman M
    J Nucl Med; 1991 Sep; 32(9):1661-7. PubMed ID: 1880565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3.
    Esteban JM; Colcher D; Sugarbaker P; Carrasquillo JA; Bryant G; Thor A; Reynolds JC; Larson SM; Schlom J
    Int J Cancer; 1987 Jan; 39(1):50-9. PubMed ID: 3793270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of colorectal carcinoma by rhenium-188-labeled B72.3 antibody in xenografted mice.
    Hosono MN; Hosono M; Zamora PO; Guhlke S; Haberberger T; Bender H; Knapp FF; Biersack HJ
    Ann Nucl Med; 1998 Apr; 12(2):83-8. PubMed ID: 9637278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of radioimmunoguided surgery in colorectal cancer using 125I-labeled carcinoembryonic antigen-specific monoclonal antibody submucosally.
    Gu J; Zhao J; Li Z; Yang Z; Zhang J; Gao Z; Wang Y; Xu G
    Dis Colon Rectum; 2003 Dec; 46(12):1659-66. PubMed ID: 14668592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
    Molinolo A; Simpson JF; Thor A; Schlom J
    Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.
    Simpson J; Schlom J
    Yale J Biol Med; 1988; 61(4):351-66. PubMed ID: 3055701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabeled monoclonal antibody B72.3 localization in metastatic lesions of colorectal cancer patients.
    Colcher D; Carrasquillo JA; Esteban JM; Sugarbaker P; Reynolds JC; Siler K; Bryant G; Larson SM; Schlom J
    Int J Rad Appl Instrum B; 1987; 14(3):251-62. PubMed ID: 3667307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer.
    Yokoyama K; Carrasquillo JA; Chang AE; Colcher D; Roselli M; Sugarbaker P; Sindelar W; Reynolds JC; Perentesis P; Gansow OA
    J Nucl Med; 1989 Mar; 30(3):320-7. PubMed ID: 2738661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of colorectal carcinoma with 131I B72.3 monoclonal antibody.
    Carrasquillo JA
    Targeted Diagn Ther; 1992; 6():45-55. PubMed ID: 1576349
    [No Abstract]   [Full Text] [Related]  

  • 15. Pilot study evaluating the intraoperative localization of radiolabeled monoclonal antibody CC83 in patients with metastatic colorectal carcinoma.
    Burak WE; Schneebaum S; Kim JA; Arnold MW; Hinkle G; Berens A; Mojzisik C; Martin EW
    Surgery; 1995 Jul; 118(1):103-8. PubMed ID: 7604370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patients.
    Gallinger S; Reilly RM; Kirsh JC; Odze RD; Schmocker BJ; Hay K; Polihronis J; Damani MT; Shpitz B; Stern HS
    Cancer Res; 1993 Jan; 53(2):271-8. PubMed ID: 8417820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and intraoperative evaluation of radiolabeled monoclonal antibody MX35 in patients with epithelial ovarian cancer.
    Rubin SC; Kostakoglu L; Divgi C; Federici MG; Finstad CL; Lloyd KO; Larson SM; Hoskins WJ
    Gynecol Oncol; 1993 Oct; 51(1):61-6. PubMed ID: 8244176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer.
    Colcher D; Milenic DE; Ferroni P; Carrasquillo JA; Reynolds JC; Roselli M; Larson SM; Schlom J
    J Nucl Med; 1990 Jul; 31(7):1133-42. PubMed ID: 2362192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody.
    Crippa F; Buraggi GL; Di Re E; Gasparini M; Seregni E; Canevari S; Gadina M; Presti M; Marini A; Seccamani E
    Eur J Cancer; 1991; 27(6):724-9. PubMed ID: 1829912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative radioimmunolocalization of colorectal carcinoma with a hand-held gamma probe and MAb B72.3: comparison of in vivo gamma probe counts with in vitro MAb radiolocalization.
    Tuttle SE; Jewell SD; Mojzisik CM; Hinkle GH; Colcher D; Schlom J; Martin EW
    Int J Cancer; 1988 Sep; 42(3):352-8. PubMed ID: 3417363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.